. . . . . "Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events"@en . . . "2013-10-29T00:00:00Z"^^ . . . . . . . . . . . "ensayo cl\u00EDnico"@es . . . . . . . . "18"^^ . . . "klinisch onderzoek"@nl . . . . . . . . "2139"^^ . . . . . . "SPIRE-LDL"@en . . . . . . "\u043A\u043B\u0456\u043D\u0456\u0447\u043D\u0435 \u0432\u0438\u043F\u0440\u043E\u0431\u0443\u0432\u0430\u043D\u043D\u044F"@uk . . "Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events"@en . . . . "\u056F\u056C\u056B\u0576\u056B\u056F\u0561\u056F\u0561\u0576 \u0583\u0578\u0580\u0571\u0561\u0580\u056F\u0578\u0582\u0574"@hy . . . . . . . . . . . . "Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events"@en . . . . "A Phase 3 Double-blind, Randomized, Placebo-controlled, Parallel-group Study To Assess The Efficacy, Long-term Safety And Tolerability Of Pf-04950615 In Subjects With Primary Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events"@en . . . . . . "clinical trial"@en . . . "ensayu cl\u00EDnicu"@ast . . . . . . . "NCT01968967" . . . . . . . . . . . "2016-07-05T00:00:00Z"^^ . .